Vanguard Portfolio Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Vanguard Portfolio Management's PRCT Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its Procept Biorobotics (PRCT) stake by 2.4% in Q3 2026, selling an estimated $1.23M and leaving 2,465,334 shares worth $44.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.
Vanguard Portfolio Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $60.6M in Q1 2026. 229 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Vanguard Portfolio Management held 2,465,334 shares of Procept Biorobotics worth $44.9M as of Q3 2026.
- Vanguard Portfolio Management sold 61,468 Procept Biorobotics shares in Q3 2026, an estimated $1.23M.
- Procept Biorobotics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1718 holding.
- Vanguard Portfolio Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Procept Biorobotics position peaked at $60.6M in Q1 2026.
- 229 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.